Cytel

Cytel specializes in providing statistical software and advanced analytics tailored for clinical trial design and execution. With over thirty years of experience, the company supports biotech and pharmaceutical firms in managing uncertainty and making evidence-based decisions. Cytel's offerings include industry-leading software, data-driven analytics, and strategic consulting, focusing on areas such as protocol development, regulatory support, and enrollment forecasting. By delivering real-world evidence and operational expertise, Cytel helps clients enhance efficiency and reduce costs in the life sciences development process.

Anand Ranade

Vice President, Finance, Personnel and Admin

3 past transactions

co.faktor

Acquisition in 2023
co.faktor GmbH is a consultancy firm that specializes in market access, medical communications, and patient relations services. The company focuses on assisting businesses in effectively targeting their audiences through the use of advanced technologies such as artificial intelligence and machine learning. By providing tailored strategies and insights, co.faktor aims to enhance client return on investment, facilitating improved customer acquisition and revenue growth. Its expertise in these areas positions co.faktor as a valuable partner for organizations seeking to navigate complex market dynamics and enhance their outreach efforts.

Stève Consultants

Acquisition in 2023
Stève Consultants is a research and consulting firm specializing in health products.

Purple Squirrel Economics

Acquisition in 2020
Purple Squirrel Economics, Inc., founded in 2016 and based in New York, New York, specializes in health economics and outcomes research consulting services. The company provides a range of services, including evidence generation, economic modeling, outcomes research, and strategic market access development. With a team of senior health economists, Purple Squirrel Economics supports clients in navigating the complexities of the healthcare industry by delivering insights that align with their objectives. The firm focuses on a variety of therapeutic areas and employs a systematic approach to literature reviews, enhancing its ability to provide comprehensive solutions in pricing, reimbursement, and market access strategies. As a subsidiary of Cytel Inc. since December 2020, the company continues to leverage its expertise to meet the evolving needs of its clients.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.